Estimation of individualized probabilities of developing breast cancer for Japanese women

Breast Cancer

Volumn 10, Issue 1, 2003, Pages 54-62

  Ueda, Kimiko ^a   Tsukuma, Hideaki ^a   Tanaka, Hideo ^a   Ajiki, Wakiko ^a   Oshima, Akira ^a  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

Breast cancer; Cumulative risk; Risk factor

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BODY MASS; BREAST TUMOR; CASE CONTROL STUDY; FEMALE; GENETIC PREDISPOSITION; GENETICS; HUMAN; INCIDENCE; JAPAN; LIFE EXPECTANCY; MENARCHE; MIDDLE AGED; PARITY; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL;

ADULT; AGE FACTORS; AGED; BODY MASS INDEX; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; JAPAN; LIFE EXPECTANCY; LOGISTIC MODELS; MENARCHE; MIDDLE AGED; MODELS, STATISTICAL; PARITY; RISK ASSESSMENT; RISK FACTORS;

EID: 0042309802     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/BF02967626     Document Type: Article

References (29)

1. The Research Group for Population-based Cancer Registration in Japan: Cancer incidence and incidence rates in Japan in 1996: estimates based on data from 10 population-based cancer registries. Jpn J Clin Onco131:410-414, 2001.
2. Gall MH, Brinton LA, Byar DP, et al: Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81:1879-1886, 1989. (Pubitemid 20026073)
3. Rockhill B, Spiegelman D, Byrne C, et al: Validation of the Gall et al. model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst 93:358-366, 2001. (Pubitemid 32229380)
4. Costantino JP, Gail MH, Pee D, et al: Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst 91:1541-1548, 1999. (Pubitemid 29457958)
5. Bondy ML, Lustbader ED, Halabi S, et al: Validation of a breast cancer risk assessment model in women with a positive family history. J Natl Cancer Inst 86:620-625, 1994. (Pubitemid 24143172)
6. Spiegelman D, Colditz GA, Hunter D, et al: Validation of the Gail et al. model for predicting individual breast cancer risk. J Natl Cancer Inst 86:600-607, 1994. (Pubitemid 24143169)
7. Gail M, Rimer B: Risk-based recommendations for mammographic screening for women in their forties. J Clin Oncol 16 3105-3114, 1998. (Pubitemid 28417433)
8. Benichou J, Gall MH, Mulvihill JJ: Graphs to estimate an individualized risk of breast cancer. J Clin Oncol 14:103-110, 1996. (Pubitemid 26020002)
9. Tung HT, Tsukuma H, Tanaka H, et al: Risk factors for breast cancer in Japan, with special attention to anthropometric measurements and reproductive history. Jpn J Clin Onco129:137-146, 1999.
10. Yuasa S, MacMahon B: Lactation and reproductive histories of breast cancer patients in Tokyo, Japan. Bull WHO 42:195-201, 1970.
11. Hirohata T, Shigematsu T, Nomura AM, et al: Occurrence of breast cancer in relation to diet and reproductive history: a case-control study in Fukuoka, Japan. Natl Cancer Inst Monogr 69:187-190, 1985. (Pubitemid 16158055)
12. Wakai K, Ohno Y, Watanabe S, et al: Risk factors for breast cancer among Japanese women in Tokyo: A case- control study. J Epidemiol 4:65-71, 1994.
13. Hirose K, Tajima K, Hamajima N, et al: A large-scale, hospital-based case-control study of risk factors of breast cancer according to menopausal status. Jpn J Cancer Res 86:146-154, 1995.
14. Hamajima N, Hirose K, Inoue M, et al: Age specific risk factors of breast cancer estimated by a case-control study in Japan.JEpidemiol 5:99-105, 1995.
15. Life expectancy. In Kokumineisei-no-doukou, Journal Health and Welfare Statistics 48 (suppl) p72, Health and Welfare Statistics Association, 2001.
16. Raymond L: Techniques of registration. Whelan SL, Young J: Classification and coding. Parkin DM, Shanmugaratnam K, Sobin L, et al: Histological groups. Parkin DM: Comparability and quality of data.
17. Ferlay J: Processing of data. In Parkin DM, Whelan SL, Ferlay J, et al. eds, Cancer incidence in five continents volume VII, IARC Sci Publ. No. 143, International Agency for Research on Cancer, Lyon, pp9-62, 1997.
18. Day DE: Cumulative rate and cumulative risk. In: Waterhouse C, Muir C, Shanmugaratnam K, et al eds Cancer Incidence in Five Continents, Volume IV, IARC Sci Publ No 42, pp443-445, 1982.
19. Nagata C, Kawakami N, Shimizu H: Trends in the incidence rate and risk factors for breast cancer in Japan. Breast Cancer Res Treat 44:75-82, 1997. (Pubitemid 27179771)
20. Lerman C, Lustbader E, Rimer B, et al: Effects of individualized breast cancer risk counseling: a randomized trial. J Natl Cancer Inst 87:286-292, 1995.
21. Black WC, Nease RF Jr, Tosteson AN: Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age. J Natl Cancer Inst 87:720-731, 1995.
22. Fisher B, Costantino JP, Wickerham DL, et al: Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90:1371-1388, 1998. (Pubitemid 28439961)
23. Fisher B, Costantino J, Redmond C, et al: A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. N Engl J Med 320:479-484, 1989. (Pubitemid 19062522)
24. Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomized trials. Lancet 351:1451-1467, 1998.
25. Narod SA, Brunet JS, Ghadirian P, et al: Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group. Lancet 356:1876-1881, 2000.
26. King MC, Wieand S, Hale K, et al: Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial. JAMA 286:2251-2256, 2001. (Pubitemid 33063147)
27. Rutqvist LE, Cedermark B, Glas U, et al: Contralateral primary tumors in breast cancer patients in a randomized trial of adjuvant tamoxifen therapy. J Natl Cancer Inst 83:1299-1306, 1991.
28. Fisher B, Redmond C: New perspective on cancer of the contralateral breast: a marker for assessing tamoxifen as a preventive agent. J Natl Cancer Inst 83:1278-1280, 1991.
29. Fisher B, Costantino JP, Redmond CK, et al: Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J Natl Cancerlnst 86:527-537, 1994. (Pubitemid 24111008)